Finally, although our meta-analysis suggested a positive association between IGF-1 and prostate cancer, however, the data generated from one study with three datasets and our Mendelian randomization results were unable to support this association, and therefore, more studies are required to confirm this finding. Here, IGF1 is linked to prostate cancer.